Welcome to our dedicated page for Iperionx SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IperionX Limited (IPX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. IperionX files annual reports on Form 20-F and furnishes current information on Form 6-K, including quarterly reports, sustainability reports, notices of annual general meeting, trading halt requests and press releases related to its titanium and critical minerals operations.
Through these filings, investors can review how IperionX describes its business as an American titanium metal and critical materials company that uses patented technologies to produce high performance titanium alloys from titanium minerals or scrap titanium. Annual and quarterly reports furnished as exhibits to Form 6-K outline the status of the Titanium Manufacturing Campus in Virginia, the Titan Critical Minerals Project in Tennessee, government funding arrangements, customer programs and risk factors associated with scaling titanium production and commercialization.
Filings also document U.S. Government support, including Defense Production Act Title III investments, Industrial Base Analysis and Sustainment awards, and the Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity contract that enables task orders for titanium components. These documents provide detail on how such programs are structured and how they relate to IperionX’s plans to expand titanium capacity and develop a mineral-to-metal supply chain.
On Stock Titan, users can view these SEC submissions as they are furnished to EDGAR and use AI-powered summaries to interpret complex sections. The platform highlights key elements of IperionX’s 20-F and 6-K exhibits, helping readers quickly understand disclosures about production capacity, government contracts, critical minerals resources, financial reporting practices and other material information contained in the company’s official filings.
IperionX Limited (IPX) filed its FY2025 Form 20‑F, highlighting continued scale-up of U.S. titanium manufacturing alongside operating losses. The company reported a net loss of
IperionX has commissioned commercial operations at its Virginia Titanium Manufacturing Campus at 125 metric tons per year, and outlined plans to scale to 1,400 metric tons per year in 2027. The company also notes the U.S. government currently holds title to certain Titanium Production Facility assets acquired with federal funds, with a possible transfer after
Shares outstanding were 319,927,854 ordinary shares as of